In an important moment for tuberculosis (TB) control, a new study finds that a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI), the study found that weekly administration of rifapentine and…
18.2 million people on antiretroviral therapy, UNAIDS
By Henry Opondo A new report by UNAIDS shows that countries are getting on the Fast-Track, with an additional one million people accessing treatment in just six months (January to June 2016). By June 2016, around 18.2 million [16.1 million–19.0 million] people had access to the life-saving medicines, including 910 000 children, double the number…
Taking the steps needed for a TB-free future
By Dr Jackson Kioko Mabel* is a 52-year-old grandmother and farmer from one of Kenya’s coastal counties and lives with her daughter and several grandchildren. She took care of her husband when he had tuberculosis (TB) about ten years ago and is currently caring for one of her grandchildren who is ill with TB at…